---
title: "AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296265581.md"
description: "AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial"
datetime: "2026-08-18T20:13:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296265581.md)
  - [en](https://longbridge.com/en/news/296265581.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296265581.md)
generator: "portal-rs"
---

# AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial


### Related Stocks

- [AMLX.US](https://longbridge.com/en/quote/AMLX.US.md)

## Related News & Research

- [BUZZ-Amylyx dips after increased $500 mln stock sale to fund blood sugar drug](https://longbridge.com/en/news/296483560.md)
- [Amylyx drug cuts low blood sugar episodes in bariatric surgery patients in key trial](https://longbridge.com/en/news/296217967.md)
- [39,241 Shares in Amylyx Pharmaceuticals, Inc. $AMLX Bought by GSA Capital Partners LLP](https://longbridge.com/en/news/296452266.md)
- [BUZZ-Amylyx Pharma starts $350 mln equity offering to fund blood sugar drug](https://longbridge.com/en/news/296266391.md)
- [Amylyx Says Phase 3 Trial of Avexitide For Post-Bariatric Hypoglycemia Met Main Goal](https://longbridge.com/en/news/296218787.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**